MEDP
MEDP
US58506Q1094
Medpace Holdings, Inc.
Loading chart...

Company Profile

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Latest News

Related stocks

RVTY
RVTY • United States
Revvity, Inc.
154.18 USD
17.2B USD 1Y +65.8%
CRL
CRL • United States
Charles River Laboratories Inte
301.79 USD
14.41B USD 1Y +71.8%
GH
GH • United States
Guardant Health, Inc.
167.47 USD
22.47B USD 1Y +153.5%
LH
LH • United States
Labcorp Holdings Inc.
312.15 USD
25.32B USD 1Y +13.2%
IQV
IQV • United States
IQVIA Holdings, Inc.
259.88 USD
42.78B USD 1Y +29.1%
WAT
WAT • United States
Waters Corporation
433.77 USD
42.59B USD 1Y +31%
A
A • United States
Agilent Technologies, Inc.
170.54 USD
48.08B USD 1Y +19.4%
ILMN
ILMN • United States
Illumina, Inc.
278.17 USD
42B USD 1Y +170.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
52.0% p.a.
Max Drawdown (5Y)
-42.9%
Sharpe Ratio (5Y)
0.45
Beta Factor
1.18
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (52.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -42.9% in the extended horizon.
ende